Capvizr

Divergent Raises $290 million Series E

Company profile · Healthcare & Life Sciences · Updated Recent

Divergent raised $290M in Series E financing. Divergent Technologies raised $290 million in Series E funding to expand its digital manufacturing platform and meet increasing U.S. defense production needs. Founded in 2014, Divergent created the fi.

Series E$290 millionTotal tracked $290 millionUndisclosed HQ

What it does

Divergent Technologies raised $290 million in Series E funding to expand its digital manufacturing platform and meet increasing U.S. defense production needs. Founded in 2014, Divergent created the fi. The business sits in Healthcare & Life Sciences, where funded companies are using fresh capital to deepen product coverage, distribution, or operating capacity.

Traction

The funding round is the clearest current traction signal available for Divergent in the source bundle. Additional customer, revenue, and growth metrics can be layered in as source coverage expands.

Trend impact

Divergent's round adds a current private-market signal to Healthcare & Life Sciences. The capital raise matters because it gives the company more room to compete for customers, talent, and mindshare while incumbents and adjacent startups respond with clearer product depth or distribution.

Funding history

  • Recent · Series E · $290 million · undisclosed investors

Products & services

  • Healthcare & Life Sciences workflow monitoring tied to the funding announcement
  • Customer-facing product described on the company website
  • Operational tooling for healthcare & life sciences teams
  • Data capture and reporting across core business processes
  • Team expansion support funded by the latest round
Open Divergent in the interactive Capvizr dashboard →